Literature DB >> 1625065

Fatty acid oxidation disorders: a new class of metabolic diseases.

D E Hale1, M J Bennett.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1625065     DOI： 10.1016/s0022-3476(05)82532-6

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  25 in total

1.  A method for comprehensive analysis of urinary acylglycines by using ultra-performance liquid chromatography quadrupole linear ion trap mass spectrometry.

Authors:  Avalyn E Lewis-Stanislaus; Liang Li
Journal:  J Am Soc Mass Spectrom       Date:  2010-09-18       Impact factor: 3.109

2.  Organic acid profiles resembling a beta-oxidation defect in two patients with coeliac disease.

Authors:  C G Costa; N M Verhoeven; C M Kneepkens; A C Douwes; R J Wanders; I T de Almeida; M Duran; C Jakobs
Journal:  J Inherit Metab Dis       Date:  1996       Impact factor: 4.982

Review 3.  Metabolic enzymes dysregulation in heart failure: the prospective therapy.

Authors:  Priyanka Parihar; Mordhwaj Singh Parihar
Journal:  Heart Fail Rev       Date:  2017-01       Impact factor: 4.214

4.  A patient with lethal cardiomyopathy and a carnitine-acylcarnitine translocase deficiency.

Authors:  K E Niezen-Koning; F J van Spronsen; L Ijlst; R J Wanders; M Brivet; M Duran; D J Reijngoud; H S Heymans; G P Smit
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

5.  Dicarboxylic aciduria, significance and prognostic indications.

Authors:  E Treacy; J Pitt; M Eggington; R Hawkins
Journal:  Eur J Pediatr       Date:  1994-12       Impact factor: 3.183

6.  Oxygenation by COX-2 (cyclo-oxygenase-2) of 3-HETE (3-hydroxyeicosatetraenoic acid), a fungal mimetic of arachidonic acid, produces a cascade of novel bioactive 3-hydroxyeicosanoids.

Authors:  Roberto Ciccoli; Shakti Sahi; Sandhya Singh; Hridayesh Prakash; Maria-Patapia Zafiriou; Ganchimeg Ishdorj; Johan L F Kock; Santosh Nigam
Journal:  Biochem J       Date:  2005-09-15       Impact factor: 3.857

7.  Cardiac-specific VLCAD deficiency induces dilated cardiomyopathy and cold intolerance.

Authors:  Dingding Xiong; Huamei He; Jeanne James; Chonan Tokunaga; Corey Powers; Yan Huang; Hanna Osinska; Jeffrey A Towbin; Enkhsaikhan Purevjav; James A Balschi; Sabzali Javadov; Francis X McGowan; Arnold W Strauss; Zaza Khuchua
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-11-27       Impact factor: 4.733

8.  Molecular basis of human mitochondrial very-long-chain acyl-CoA dehydrogenase deficiency causing cardiomyopathy and sudden death in childhood.

Authors:  A W Strauss; C K Powell; D E Hale; M M Anderson; A Ahuja; J C Brackett; H F Sims
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-07       Impact factor: 11.205

9.  Successful Treatment of Cardiomyopathy due to Very Long-Chain Acyl-CoA Dehydrogenase Deficiency: First Case Report from Oman with Literature Review.

Authors:  Sharef Waadallah Sharef; Khalfan Al-Senaidi; Surendra Nath Joshi
Journal:  Oman Med J       Date:  2013-09

10.  Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency: diagnosis by acylcarnitine analysis in blood.

Authors:  J L Van Hove; W Zhang; S G Kahler; C R Roe; Y T Chen; N Terada; D H Chace; A K Iafolla; J H Ding; D S Millington
Journal:  Am J Hum Genet       Date:  1993-05       Impact factor: 11.025
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.